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doi:10.1016/j.jtcvs.2006.11.035bjective: Extracellular matrix scaffolds have been successfully used for myocar-
ial wall repair. However, regional functional evaluation (ie, contractility, electrical
onductivity) of the extracellular matrix scaffold during the course of remodeling
as been limited. In the present study, we evaluated the remodeled scaffold for
vidence of electrical activation.
ethods: The extracellular matrix patch was implanted into the porcine right
entricular wall (n  5) to repair an experimentally produced defect. Electrome-
hanical mapping was performed with the NOGA system (Biosense Webster Inc,
iamond Bar, Calif) 60 days after implantation. Linear local shortening was
ecorded to assess regional contractility. After sacrifice, detailed histologic exami-
ations were performed.
esults: Histologic examinations showed repopulation of the scaffold with cells,
ncluding a monolayer of factor VIII–positive cells in the endocardial surface and
ultilayered -smooth muscle actin–positive cells beneath the monolayer cells. The
-smooth muscle actin–positive cells tended to be present at the endocardial aspect
f the remodeled scaffold and at the border between the remodeled scaffold and the
ormal myocardium. Electromechanical mapping demonstrated that the patch had
ow-level electrical activity (0.56  0.37 mV; P  .0001) in most areas and
oderate activity (2.20 0.70 mV; P .0001) in the margin between the patch and
he normal myocardium (7.58  2.23 mV).
onclusions: The extracellular matrix scaffolds were repopulated by -smooth
uscle actin–positive cells 60 days after implantation into the porcine heart. The
resence of the cells corresponded to areas of the remodeling scaffold that showed
arly signs of electrical conductivity.
eart failure is a major health problem with increasing prevalence, caused in
part by the increased survivals for patients who have had acute myocardial
infarction, increased life expectancy, and lifestyle choices. Postinfarction left
entricular (LV) remodeling is characterized by LV dilatation and abnormal geometry
ncluding development of LV aneurysm leading to congestive heart failure.
Although heart transplantation is currently the best surgical option for this
isease, there are many practical reasons for not making it the first choice for every
atient. A shortage of donor organs and increased age, pulmonary hypertension, and
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EThronic organ failure of the recipient are factors that limit
he number of heart transplants, which reached a plateau in
ecent years.1 There are about 50,000 deaths per year rel
o congestive heart failure, yet there are only about 2000
eart transplantations per year.2 Mechanical support tech-
ologies such as LV assist systems (LVAS) have been
eveloped to compensate for the lack of available donor
rgans and as a bridge to transplantation. However, this
herapy is limited by infection, cost, durability, and
hromboembolism.3
Surgical ventricular restoration (SVR) is an important
trategy for effective treatment of postinfarction heart fail-
re. Most SVR, like the septal anterior ventricular exclusion
r the Calafiore procedures, involves the placement of a
ynthetic cardiac patch, such as Dacron and Teflon, to
estore the geometry of the heart.4,5 These patches are ine
aterials that are rapidly encapsulated by the host and do
ot restore myocardial function. For SVR to serve as a
eplacement for transplantation as opposed to a temporary
elay, new patch materials that promote the formation of
unctional myocardial tissue will be required.
Recently, naturally occurring extracellular matrix (ECM)
caffolds have been successfully used for the repair of a
ariety of tissues in preclinical studies and clinical applica-
ions.6-9 ECM is degraded quickly after implantation 
romotes site-specific tissue remodeling. Urinary bladder
atrix (UBM) is one such promising ECM scaffold material
hat has shown promise for myocardial repair.10-13 Kochu-
ura and associates12 demonstrated that a UBM scaffo
laced in right ventricular (RV) walls of dogs was re-
opulated by myocytes. The remodeled UBM scaffold
estored some regional mechanical function as determined
ith computer-aided speckle interferometry. Robinson and
olleagues13 showed successful replacement of LV w
efects in a porcine model using UBM scaffolds, but re-
ional function was not evaluated.
The current study was designed to confirm the finding
hat an ECM scaffold used to repair the myocardial wall is
epopulated by myocytes in a porcine model. Inasmuch as it
as shown previously that a UBM patch improves the
Abbreviations and Acronyms
ECM  extracellular matrix
ICE  intracardiac echocardiography
LLS  linear local shortening
LV  left ventricular
LVAS left ventricular assist system(s)
RV  right ventricular
SMA  smooth muscle actin
SVR  surgical ventricular restoration
UBM  urinary bladder matrixlobal and regional function of the heart, the current study o
80 The Journal of Thoracic and Cardiovascular Surgery ● Aprilso aimed to determine whether the myocytes contributed
lectromechanical function to the remodeled UBM scaffold.
lectromechanical assessment was performed with a NOGA-
tar mapping system (Biosense Webster Inc, Diamond Bar,
alif) with an intracardiac echocardiography (ICE) sys-
em. There is typically a direct relationship between elec-
rophysiologic parameter with NOGA and myocardial via-
ility.14,15 The combination of the ICE system with 
OGA-Star system permitted stable endocardial contact at
ach mapped site. In addition, ICE guidance displayed
chocardiographically distinct anatomic landmarks (eg, mi-
ral valve leaflets, chordae tendineae, ventricular wall thin-
ing/akinesis/dyskinesis, endocardial thrombus) to aid
avigation.
aterials and Methods
BM Scaffold Preparation
orcine urinary bladders were harvested from market weight pigs
approximately 110-130 kg) immediately after they were put to
eath. After repeated washes with tap water, the urothelial layer
as removed by soaking of the material in 1N saline. The tunica
erosa, tunica muscularis externa, tunica submucosa, and most of
he muscularis mucosa were mechanically delaminated from the
emaining bladder tissue. The remaining basement membrane of
he tunica mucosa and the subjacent tunica propria, collectively
ermed UBM, were then decellularized and disinfected by immer-
ion in 0.1% peracetic acid and 4% ethanol solution for 2 hours
nd rinsed in phosphate-buffered saline.16
A four-layer construct of the hydrated sheets of UBM was
reated such that the basement membrane was exposed on either
ide of the sheet. The four-layer construct was then laminated by
vacuum-pressing technique. The construct was placed between
wo perforated stainless steel sheets, and the stainless steel plates
ere placed between sheets of sterile gauze. The entire construct
as then sealed in vacuum bagging and subjected to a vacuum of
10 to 730 mm Hg for approximately 8 hours. The final device was
.1 mm in thickness and terminally sterilized by exposure to
thylene oxide. The device was rehydrated in saline just before the
peration.16 These scaffolds were identical to scaffolds used 
revious study for LV wall repair.13
nimal Operations
ive Duroc cross pigs weighing 44 to 50 kg were used. The study
as approved by the Institutional Animal Care and Use Committee
f the University of Pittsburgh and carried out in compliance with
he “Principles of Laboratory Animal Care” formulated by the
ational Society for Medical Research and the “Guide for the Care
nd Use of Laboratory Animals” prepared by the National Acad-
my of Sciences and published by the National Institutes of Health
NIH Publication No. 85-23, revised 1985).
urgical Procedure
nesthesia was induced with ketamine (20 mg/kg) and xylazine
2 mg/kg) and maintained with 2.0% isoflurane inhalation. The
ericardium was opened through a right anterolateral thoracot-
my in the fourth intercostal space. After the positioning of a
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ETangential clamp, a small portion of the RV free wall was substi-
uted with a UBM patch (20  20 mm) with a 5-0 continuous
olypropylene suture (Figure 1, A). The chest was closed. At 
ays after implantation, electrophysiologic mapping was per-
ormed, after which the animals were put to death for histologic
xamination.
lectromechanical Mapping
lectromechanical mapping was performed with the NOGA map-
ing system. The system uses synchronous extracorporeal mag-
etic fields projected into the thoracic space to determine the
ocation and orientation of a sensor mounted near the distal elec-
rode of a deflectable bipolar mapping catheter (NOGA-Star, Bio-
ense Webster Inc; 2-mm length tip electrode, 2-mm length ring
lectrode, 1-mm length interelectrode spacing), which can be used
o access the endocardial surface.17 An ICE system (AcuNAV
cuson Siemens, Mountain View, Calif) was used together with
OGA to ensure proper placement of the NOGA-Star catheter.
he AcuNAV system consists of a 10F deflectable catheter incor-
orating a phased-array transducer with programmable operating
requency.18
Use of NOGA with ICE has been previously described.19 In
rief, the NOGA-Star catheter is introduced into the RV cavity via
he right femoral vein. The ICE catheter is placed into the right
trium through the same approach. Endocardial mapping of the
ntire endocardial surface was performed during sinus rhythm. The
cquired point density for non-free RV walls was 5/cm2; the density
or the RV free wall was 10/cm2.
echanical Mapping
egional contractility was evaluated by calculating the linear localhortening (LLS). The algorithm calculated the fractional shorten- r
The Journal of Thoracicng of regional endocardial surface at end-systolic phase as previ-
usly described.20
istology and Immunochemistry
xcised tissues were fixed in 10% formalin, embedded in paraffin, cut
nto 5-m sections, and placed on a histology slide. The sections
ere then deparaffinized and either stained with hematoxylin-
osin and Masson trichrome or prepared for immunohistochemical
taining. Monoclonal antibodies specific for factor VIII–related
ntigen (Dako, Carpinteria, Calif) and -smooth muscle actin
-SMA) (Dako) were used. The immunoreaction was detected
ith 3,3-diaminobenzidine.
tatistical Analysis
ll values are expressed as the mean  standard deviation. The
tatistical differences in all data were determined by a Mann–
hitney test.
esults
ortality and Morbidity
ll pigs (n  5) survived without any complications until
lectively being put to death. The pigs were killed after a
apping 60 days after implantation.
acroscopic Examination
either aneurysm nor infection was noted in the implanted
egments at death (Figure 1, B). The area of the patch 
ot change considerably over the course of remodeling.
ontraction of the RV wall was uniform, and the patch
Figure 1. A, Intraoperative view. The
tissue-engineered patch is placed on
the right ventricular wall. B, No infec-
tion and aneurysm are noted on the
patch 60 days after implantation (ar-
row). C, Endocardial side of the patch.
White tissue is observed. There is no
thrombus in the right ventricle. D,
Cross section of the patch. The patch
region is as thick as the adjoining right
ventricular wall.egion was not dyskinetic. The epicardial side of the remod-
and Cardiovascular Surgery ● Volume 133, Number 4 981
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ETled UBM scaffold was covered with fibrous connective
issues. The endocardial side of the remodeled tissue was
mooth and white with no thrombus around the patch region
Figure 1, C). In a cross section, the whole patch re
onsisted of white firm tissue. The thickness of the ECM
atch increased so that it approached the thickness of the
djacent normal myocardial wall (Figure 1, D).
istology and Immunochemistry
ixty days after implantation, the histologic examination of
he remodeled UBM scaffold showed a population of round
nd spindle-shaped cells (Figure 2, A). No evidence fo
nflammation was noted. Vascularity was noted in the mid-
le and in the epicardial aspect in the remodeled specimen
Figure 2, B). The cells present within the remodeled U
caffold consisted of a monolayer of factor VIII–positive
ells on the endocardial surface (Figure 2, C ) and mul
ilayered -SMA–positive cells (Figure 2, D) distributed w
82 The Journal of Thoracic and Cardiovascular Surgery ● Aprihroughout the remodeled tissue. The Masson trichrome
tain showed that the remodeled UBM patch consisted of
ensely organized collagenous tissue. These cells were
resent predominantly at the endocardial aspect of the re-
odeled scaffold and at the margin between the remodeled
caffold and the normal myocardium (Figure 2, E and F).
lectromechanical Mapping
ocal unipolar and bipolar voltage electrograms were re-
orded. More than 200 discrete points were used to map the
egion of ECM remodeling. The electrical information was
resented as 3-dimensional maps displayed in a color-coded
ashion (Figure 3). Electrogram amplitude values w
raphed out in Figure 4, A. The mean electrogram of t
ormal myocardial area (displayed in violet) was 7.58 
.23 mV. The central part of the patch (displayed in red)
as representative of abnormal electromechanical function,
Figure 2. Histologic preparations of
the patch 60 days after implantation. A,
A good repopulation of cells was ob-
served. B, There was some vasculo-
genesis in the middle of the patch. C, A
monolayer of endothelial cells covered
the surface of the tissue. D, Multilay-
ered myocytes were observed beneath
the monolayer cells. E, Central part of
the patch. Regenerated cells were
prone to be unevenly distributed in the
endocardial aspect at the around cen-
ter of the patch. F, Marginal part of the
patch. The myocytes extended across
full thickness at the edge of the patch.
(A and B, hematoxylin– eosin stain; C,
factor VIII stain; D, -smooth muscle
actin stain; E and F, Masson trichrome
stain. (Magnifications A, B, C, and D
100; E and F 40.)ith low electrical activity (0.56  0.37 mV; P  .0001 vs
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ETreen, violet zone). In the margin between the patch and the
ormal myocardium, there was a band of moderate electri-
al activity approximately 5 mm in width (displayed in
reen and yellow) that had a mean voltage of 2.20  0.70
V (P  .0001 vs violet zone). The LLS was 14.69% 
.73% in the normal myocardium and 1.48%  2.43% in
he UBM patch (Figure 4, B). Figure 5 shows a comparis
etween the patch region of the macrograph and that of the
lectrical map. Each figure was adjusted in its direction and
cale for precise comparison. It demonstrates that the patch
egion involved the area displayed in yellow and green in
igure 3. Color-coded electrical map using NOGA. Bipolar elec-
rogram amplitude map. Red demarcates peak-to-peak ampli-
ude < 0.5 mV; violet > 5.0 mV.The Journal of Thoraciche electrical map in which the mean of electrical amplitude
as significantly higher than in the area displayed in red.
iscussion
ongestive heart failure is frequently a progressive disease
hat can be difficult to control with conservative treatme21
he final treatment option for patients with end-stage con-
estive heart failure is transplantation. Inasmuch as there is
shortage of donor organs, SVR has become an important
urgical treatment option with demonstrated benefit.22 How-
ver, a limitation of traditional SVR is the use of an inert
atch material such as Dacron that cannot remodel into
unctional myocardial tissue and, as a result, provides no
unctional improvement to the treated heart. The UBM
ardiac patch that has a potential to be functional myocar-
ium can contribute to improving the outcome of SVR.
Recently, a number of tissue-engineered scaffolds have
een evaluated for use in myocardial repair, including ECM
caffolds derived from the porcine urinary bladder, as an
lternative to synthetic cardiac patches in both the RV
nd LV wall.9,11-13,23,24 It has been shown that UBM sc-
olds can endure the high-pressure environment of the LV
nd are rapidly repopulated by a variety of cell types,
ncluding cardiac myocytes.9,11-13 The source of these ce
s still under investigation, but recent studies have shown
hat ECM scaffolds recruit a population of circulating bone
arrow–derived cells that may differentiate down a tissue-
pecific lineage in response to local environmental cues.25-27
s a result of the this site-specific remodeling, regional
echanical function was improved.11,12 The results of th
urrent study compare very well with the histologic and
echanical results shown in the previous studies. Histologic
xamination showed a number of myocytes distributed
hroughout the remodeled scaffold, with the majority of the
ells located at the endocardial aspect and at the junction
Figure 4. A, Electrogram amplitude
graph. Central zone corresponds to the
area displayed in red in Figure 3. Mar-
ginal zone corresponds to yellow and
green. Normal zone corresponds to vi-
olet. B, A graph of the linear local
shortening. LLS, Linear local shorten-
ing; UBM, urinary bladder matrix.and Cardiovascular Surgery ● Volume 133, Number 4 983
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ETith the adjacent normal myocardium. Keck and col-
eagues14 reported that an LLS threshold of 4% identi
ignificant regional contractility disturbances of akinetic or
yskinetic segments with a specificity of 85% and that of
% defined a normally contracting segment with a sensitiv-
ty of 90%. With a mean LLS below 4%, these results nearly
oincided with those of Kochupura and colleagues,12 sug-
esting that the regional function of the remodeled scaffold
s still immature at 60 days of remodeling. In addition, it
emonstrated that regeneration of the electrical activity was
ot relative to that of the contractility.
These results correspond well with the electrophysi-
logic function of the remodeled scaffold determined in this
tudy. Although there was essentially no electrical potential
n the center of the remodeled scaffold, there was a region
f low activity area around the periphery of the remodeling
rea. The region that showed the greatest electrical potential
as co-localized with the region that contained the largest
umber of cardiac myocytes. It is possible that as remodel-
ng of the ECM scaffold progresses, as suggested by earlier
tudies,10 more myocytes would populate the center reg
f the remodeled graft, further improving the electrome-
hanical properties of the tissue.
Limitations of the present study include evaluation of the
lectromechanical properties of the remodeling tissue at
nly one time point and the lack of control experiments in
hich synthetic cardiac patches were used, inasmuch as this
s a preliminary study. Furthermore, the number of animals
as relatively small. This study was meant to confirm the
ndings of previous studies to develop a better understand-
ng of the remodeling of an ECM scaffold in the myocardial
ocation. Longer term studies are planned to determine
hether the remodeling of a UBM scaffold progresses andontinues to improve the regional cardiac function. Once the
84 The Journal of Thoracic and Cardiovascular Surgery ● Apriemodeling of an ECM scaffold is fully characterized in a
ormal heart, future studies will be conducted in a disease-
ppropriate model (ie, postinfarction heart failure) to deter-
ine whether an ECM scaffold remains beneficial.
In conclusion, this study confirms that UBM is a prom-
sing scaffold for tissue-engineered cardiac patch repair
ith no adverse events and that site-appropriate contractile
ells participate in the remodeling process. The combination
f the NOGA-Star system with the ICE system showed
fficacy for evaluating the electromechanical properties of a
emodeled tissue-engineered scaffold for cardiac repair.
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